Mereo BioPharma MREO
NASDAQ MREO
$0.29 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Gross Profit (2023 - 2025)

Updated

Mereo BioPharma's Gross Profit came in at $367,000 for FY2025.

Analysis

Mereo BioPharma (MREO) Gross Profit (2023 - 2025) Analysis & Trends

Going back to FY2021, Mereo BioPharma's Gross Profit data covers 4 years.

  • Gross Profit carries a four-year compound annual growth rate of -65.2% (FY2021 to FY2025).
  • The FY2025 figure represents the lowest annual Gross Profit since FY2022.
  • Per Business Quant, earlier years put Gross Profit at $7.43 million in FY2023, -$1.15 million in FY2022 and $25.01 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Mereo BioPharma 46.31 Mn -103.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 368,000.00
Dec 31, 2023 1.27 Mn
Sep 30, 2023 -235,000.00
Jun 30, 2023 5.57 Mn
Mar 31, 2023 -347,000.00
API Access

Mereo BioPharma Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=MREO&period=max&api_key=YOUR_API_KEY